Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose fluoxetine effects on cortical activity during movement observation in chronic stroke
NL-OMON26776Not yet recruiting
- Sponsor
- Roessingh Research & Development
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fluoxetine in stroke (2 arms), sponsored by Roessingh Research & Development. Primary endpoint: Change in cortical activity. Planned start Aug 2008; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on NL-OMON26776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26776.